Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

GINA KOLATA
Author: GINA KOLATA

Advertisements
{ "slotId": "6845006044", "unitType": "responsive", "resize": "auto" }

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.